A Portfolio of Fixed Income, Pass Throughs and Small Caps

 | Apr 20, 2017 | 3:00 PM EDT
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

cpe-a

,

nap

,

arr

,

cmo

,

newt

,

nm

,

trch

,

gst

,

epm

,

gemp

,

icad

The most challenging -- and fun -- part of my job as an investment advisor is constructing a new portfolio. As I use a "fee-only" model, I never put my clients in funds or ETFs that have embedded expense ratios and up-front sales loads. No, I pick individual securities, and I am fortunate enough to be starting with new clients this week. So, the question anyone in finance is asked at cocktail parties "what are you buying" becomes the more time-sensitive "what are you buying NOW?" Building portfolios is not an easy task, especially since I try to keep my clients fully invested at all times.

So, what am I buying NOW? It's a mix of the securities I have written about for Real Money over the past few months, plus a few new ideas. Philosophically, the asset allocation is still the same: heavy on corporate fixed-income securities, mezzanine securities (preferred) pass-through securities (BDC-RICs, REITs) and a common stock component that is entirely composed of small-capitalization stocks.

It may look like a dog's breakfast, but actually this type of portfolio will produce steady returns in a flat-to-down market. I have no idea when the Trump Jump will end, but I know that equity valuations are currently at cycle-highs, and I need to beat that market. With a blended yield in the 6%-8% range, my portfolios have guaranteed returns that the S&P 500 -- current yield 1.94% -- sorely lacks.

So, in each of those buckets, here are some individual names I plan to buy this week and next.

Corporate Fixed Income:

As with stocks, I feel that energy offers the most return among fixed-income securities. My favorite name in the space remains Callon Petroleum's 10% Series A prefs (CPE-A)  These prefs, astoundingly, still yield 9.46%. The oil bust has already happened. These are not risky securities and although there is call risk (first call date is 5/30/2018) there is no reason CPE-A should be yielding more than 4x the benchmark 10-year Treasury.

Pass-Throughs:

My favorite here remains Navios Maritime Midstream Partners (NAP) . NAP is a master limited partnership registered as C-Corp. and its 14.1% current yield more than adequately reflects the risk inherent in its fleet of 6 VLCC oil tankers. I also like the mortgage REITs (ARMOUR Residential REIT (ARR) ,Capstead Mort RE Rg (CMO) ) and certain BDC-RICs here, especially Newtek (NEWT)

Small stocks:

These are covered in my newsletter, MicroCap Guru. The biggest winner so far has been Navios Maritime (NM) . The preferreds put me easily on top of the Real Money Best Ideas list, but, today, I see much more upside in the common. It's nearly doubled since I featured it in MCG Issue 1 in August, but I'm still buying more.

ln a recent RM column I recommended purchase of three small energy names -- Evolution Petroleum (EPM) , Gastar Exploration (GST) and Torchlight Energy (TRCH)  -- and I'm still buying all three at current prices.

Also, though I am certainly not an expert, I try to keep some exposure to medtech and biopharma. Gemphire Therapeutics (GEMP)  has been a strong performer since I mentioned it in the MCG and in Real Money, but I think that one has a long way to run with recently raised capital being directed toward clinical trials.

A new name I have been adding is iCAD (ICAD) . The shares are still trading at less than half of their mid-2015 value and 2016 financial results showed a company in transition. I believe we are near the most lucrative of investing events for iCAD, the inflection point. I look for revenue growth to begin anew as we move through 2017 and for positive results for the stock from upcoming industry presentations and new data releases. I had a very smart PM with a background at a very large Boston-based fund manager describe iCAD to me as the "next Intuitive Surgical" and if ICAD performs anywhere near as well as ISRG has, it will truly be a winner for my clients and me.

Columnist Conversations

COST is beginning to firm up near the $150.00 area. The stock bottomed here at last December's lows before exp...
We like this move today on good turnover and strong option flow. BOUGHT FCX OCT 15 CALL AT 1.04
View Chart »  View in New Window » So far we are holding key support in this one.  Target...

BEST IDEAS

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.